SeaStar Medical Holding Corporation
ICU
$4.14
$0.276.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 129.51% | -45.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 129.51% | -45.86% | |||
| Cost of Revenue | -14.29% | -48.15% | |||
| Gross Profit | 141.42% | -45.66% | |||
| SG&A Expenses | -35.51% | 84.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.67% | 79.66% | |||
| Operating Income | 15.73% | -103.82% | |||
| Income Before Tax | 16.36% | -73.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.36% | -73.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.36% | -73.43% | |||
| EBIT | 15.73% | -103.82% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 39.05% | 25.56% | |||
| Normalized Basic EPS | 39.05% | 25.55% | |||
| EPS Diluted | 39.05% | 25.56% | |||
| Normalized Diluted EPS | 39.05% | 25.55% | |||
| Average Basic Shares Outstanding | 37.22% | 132.95% | |||
| Average Diluted Shares Outstanding | 37.22% | 132.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||